Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Electronic Health Records | 9 | 2020 | 3492 | 1.11 | Why? |
| Machine Learning | 5 | 2021 | 4395 | 0.46 | Why? |
| Precision Medicine | 2 | 2020 | 1477 | 0.45 | Why? |
| Software | 2 | 2019 | 2501 | 0.43 | Why? |
| New York City | 15 | 2021 | 7432 | 0.42 | Why? |
| Biological Specimen Banks | 2 | 2020 | 1142 | 0.22 | Why? |
| Acute Kidney Injury | 4 | 2021 | 5762 | 0.21 | Why? |
| Hemorrhage | 3 | 2020 | 3013 | 0.19 | Why? |
| Receptor, Melanocortin, Type 4 | 1 | 2018 | 2 | 0.19 | Why? |
| Mucus | 1 | 2020 | 183 | 0.18 | Why? |
| Fibrillar Collagens | 1 | 2017 | 6 | 0.18 | Why? |
| Collagen Diseases | 1 | 2017 | 10 | 0.18 | Why? |
| Computers | 1 | 2019 | 199 | 0.18 | Why? |
| Genome, Human | 2 | 2018 | 400 | 0.17 | Why? |
| Immunity, Mucosal | 1 | 2021 | 426 | 0.17 | Why? |
| Macular Degeneration | 1 | 2020 | 194 | 0.17 | Why? |
| Adaptation, Biological | 1 | 2018 | 179 | 0.17 | Why? |
| Hospitalization | 10 | 2021 | 54280 | 0.17 | Why? |
| Exome | 1 | 2018 | 207 | 0.17 | Why? |
| Prefrontal Cortex | 1 | 2018 | 151 | 0.16 | Why? |
| Quantitative Trait Loci | 1 | 2018 | 340 | 0.16 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.16 | Why? |
| Loss of Function Mutation | 1 | 2018 | 244 | 0.15 | Why? |
| Post-Exposure Prophylaxis | 1 | 2020 | 472 | 0.15 | Why? |
| Renal Dialysis | 3 | 2021 | 4358 | 0.15 | Why? |
| Anticholesteremic Agents | 1 | 2017 | 186 | 0.14 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.14 | Why? |
| Hospital Mortality | 8 | 2021 | 22087 | 0.14 | Why? |
| Genome-Wide Association Study | 2 | 2018 | 1648 | 0.13 | Why? |
| Complement Activation | 1 | 2020 | 949 | 0.13 | Why? |
| HIV | 1 | 2020 | 1116 | 0.13 | Why? |
| Wearable Electronic Devices | 1 | 2021 | 694 | 0.13 | Why? |
| Renal Insufficiency | 1 | 2020 | 810 | 0.13 | Why? |
| Intestinal Mucosa | 1 | 2021 | 1046 | 0.12 | Why? |
| Policy | 1 | 2021 | 1372 | 0.12 | Why? |
| Databases, Factual | 2 | 2019 | 6248 | 0.12 | Why? |
| Biological Evolution | 1 | 2018 | 641 | 0.12 | Why? |
| Models, Statistical | 2 | 2021 | 5312 | 0.11 | Why? |
| Observational Studies as Topic | 1 | 2019 | 1887 | 0.11 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.11 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.11 | Why? |
| Heart Rate | 1 | 2021 | 1527 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Data Mining | 1 | 2017 | 767 | 0.11 | Why? |
| Polymorphism, Genetic | 1 | 2018 | 1074 | 0.11 | Why? |
| Patient Readmission | 1 | 2020 | 1543 | 0.11 | Why? |
| Obesity | 3 | 2021 | 7388 | 0.11 | Why? |
| Anticoagulants | 3 | 2020 | 9563 | 0.10 | Why? |
| Lymphocytes | 2 | 2020 | 3056 | 0.10 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.10 | Why? |
| Respiration, Artificial | 5 | 2021 | 22116 | 0.10 | Why? |
| Atherosclerosis | 1 | 2017 | 768 | 0.10 | Why? |
| Learning | 1 | 2017 | 1181 | 0.10 | Why? |
| Comorbidity | 7 | 2021 | 34796 | 0.09 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.09 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.09 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.09 | Why? |
| Humans | 38 | 2021 | 930598 | 0.09 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.09 | Why? |
| Myocardium | 1 | 2020 | 2323 | 0.09 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.09 | Why? |
| Noninvasive Ventilation | 1 | 2021 | 2329 | 0.09 | Why? |
| Schizophrenia | 1 | 2018 | 1018 | 0.09 | Why? |
| Algorithms | 3 | 2019 | 7346 | 0.08 | Why? |
| Thromboembolism | 1 | 2020 | 2101 | 0.08 | Why? |
| Heterozygote | 2 | 2018 | 249 | 0.08 | Why? |
| Homozygote | 2 | 2018 | 230 | 0.08 | Why? |
| Thrombocytopenia | 1 | 2020 | 2093 | 0.08 | Why? |
| Critical Care | 2 | 2020 | 14081 | 0.08 | Why? |
| Cohort Studies | 5 | 2021 | 36005 | 0.08 | Why? |
| Cardiovascular Diseases | 3 | 2020 | 11497 | 0.08 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.08 | Why? |
| Aged, 80 and over | 9 | 2021 | 88759 | 0.07 | Why? |
| Gastrointestinal Diseases | 1 | 2021 | 2580 | 0.07 | Why? |
| Aged | 16 | 2021 | 215776 | 0.07 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 1510 | 0.07 | Why? |
| Viral Load | 3 | 2021 | 15850 | 0.07 | Why? |
| Emergency Service, Hospital | 2 | 2020 | 14232 | 0.07 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.07 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.07 | Why? |
| Diabetes Complications | 1 | 2017 | 2358 | 0.07 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.07 | Why? |
| Male | 20 | 2021 | 367725 | 0.07 | Why? |
| Retrospective Studies | 12 | 2021 | 105322 | 0.07 | Why? |
| Risk Assessment | 4 | 2021 | 25439 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Female | 20 | 2021 | 380317 | 0.07 | Why? |
| Risk Factors | 10 | 2021 | 71621 | 0.07 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.07 | Why? |
| Myocardial Infarction | 1 | 2020 | 3361 | 0.07 | Why? |
| Hospitals | 2 | 2020 | 11793 | 0.07 | Why? |
| Causality | 2 | 2018 | 857 | 0.07 | Why? |
| Proportional Hazards Models | 3 | 2021 | 6543 | 0.07 | Why? |
| Treatment Outcome | 5 | 2020 | 51732 | 0.06 | Why? |
| Age Factors | 3 | 2020 | 21039 | 0.06 | Why? |
| Sepsis | 1 | 2020 | 3517 | 0.06 | Why? |
| Artificial Intelligence | 1 | 2018 | 3543 | 0.06 | Why? |
| Cardiology | 1 | 2018 | 2873 | 0.06 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.06 | Why? |
| CD57 Antigens | 1 | 2021 | 96 | 0.06 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.06 | Why? |
| Pandemics | 12 | 2020 | 389249 | 0.06 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.06 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| CD56 Antigen | 1 | 2021 | 193 | 0.05 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.05 | Why? |
| African Americans | 1 | 2016 | 3363 | 0.05 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.05 | Why? |
| Gene Conversion | 1 | 2018 | 3 | 0.05 | Why? |
| Proprotein Convertase 1 | 1 | 2018 | 3 | 0.05 | Why? |
| Pro-Opiomelanocortin | 1 | 2018 | 6 | 0.05 | Why? |
| Receptors, Leptin | 1 | 2018 | 12 | 0.05 | Why? |
| alpha-MSH | 1 | 2018 | 17 | 0.05 | Why? |
| Hospitals, Private | 1 | 2020 | 198 | 0.05 | Why? |
| Heart Failure | 1 | 2020 | 6638 | 0.05 | Why? |
| Hematuria | 1 | 2020 | 284 | 0.05 | Why? |
| Cells, Cultured | 2 | 2021 | 5835 | 0.04 | Why? |
| Anti-Obesity Agents | 1 | 2018 | 52 | 0.04 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Adult | 9 | 2021 | 244371 | 0.04 | Why? |
| Urine | 1 | 2020 | 469 | 0.04 | Why? |
| Blood Coagulation | 2 | 2020 | 2768 | 0.04 | Why? |
| Proteinuria | 1 | 2020 | 474 | 0.04 | Why? |
| Multigene Family | 1 | 2017 | 377 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Risk Adjustment | 1 | 2020 | 730 | 0.04 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.04 | Why? |
| Monte Carlo Method | 1 | 2018 | 577 | 0.04 | Why? |
| Hospitals, Urban | 1 | 2020 | 950 | 0.04 | Why? |
| Circadian Rhythm | 1 | 2021 | 607 | 0.04 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.03 | Why? |
| Hypertension | 3 | 2020 | 8895 | 0.03 | Why? |
| Leukocytes | 1 | 2020 | 1046 | 0.03 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.03 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.03 | Why? |
| Cholesterol | 1 | 2017 | 660 | 0.03 | Why? |
| Genetic Predisposition to Disease | 2 | 2018 | 4027 | 0.03 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.03 | Why? |
| New York | 1 | 2020 | 2488 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Length of Stay | 2 | 2020 | 11042 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2019 | 15909 | 0.03 | Why? |
| Epigenesis, Genetic | 1 | 2018 | 711 | 0.03 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.03 | Why? |
| Datasets as Topic | 1 | 2018 | 1404 | 0.03 | Why? |
| Coronary Vessels | 1 | 2017 | 914 | 0.02 | Why? |
| Musculoskeletal Diseases | 1 | 2017 | 646 | 0.02 | Why? |
| Gene Expression | 1 | 2020 | 3332 | 0.02 | Why? |
| Cerebrovascular Disorders | 1 | 2018 | 1040 | 0.02 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 1645 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Diagnostic Imaging | 1 | 2018 | 1044 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| Blood Coagulation Disorders | 1 | 2020 | 2040 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2017 | 3239 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Intubation, Intratracheal | 1 | 2020 | 3962 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.02 | Why? |
| Computer Simulation | 1 | 2018 | 4982 | 0.02 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Italy | 1 | 2021 | 38444 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
Glicksberg's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(348)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_